Filter Results:
(1,370)
Show Results For
- All HBS Web
(1,370)
- People (1)
- News (340)
- Research (782)
- Events (3)
- Multimedia (38)
- Faculty Publications (495)
Show Results For
- All HBS Web
(1,370)
- People (1)
- News (340)
- Research (782)
- Events (3)
- Multimedia (38)
- Faculty Publications (495)
- Program
Launching New Ventures
learning model has been carefully designed to facilitate your growth. Your learning will take place on your own, in your living group, and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & Safety... View Details
- Program
Rising Generation in the Family Enterprise
designed to facilitate your growth. Your learning will take place on your own, in your living group, and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & Safety Protocols Admissions Criteria and... View Details
- Program
Growing as a Purposeful Leader
larger classroom, driven by the renowned HBS case method. Review Our Campus Health & Safety Protocols Admissions Criteria and Process We admit candidates to specific sessions on a rolling, space-available basis, and encourage you to apply... View Details
- Program
Foundations of Private Equity and Venture Capital
Campus Health & Safety Protocols Admissions Criteria and Process We admit candidates to specific sessions on a rolling, space-available basis, and encourage you to apply as early as possible. Although most programs have no formal... View Details
- Program
Families in Business
your growth. Your learning will take place on your own, in your living group, and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & Safety Protocols Admissions Criteria and Process We admit... View Details
- Program
The HR-Executive Suite Connection
immersive experience where every aspect of the learning model has been carefully designed to facilitate your growth. Your learning will take place on your own, in your living group, and in the larger classroom, driven by the renowned HBS case method. Review Our Campus... View Details
- 2024
- Article
Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway
By: Mateo Aboy, Cristina Crespo and Ariel Stern
Moderate-risk medical devices constitute 99% of those that have been regulated by the U.S. Food and Drug Administration (FDA) since it gained authority to regulate medical technology nearly five decades ago. This article presents an analysis of the interaction between... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Care and Treatment; Technology Adoption; Technological Innovation; Safety; Medical Devices and Supplies Industry; United States
Aboy, Mateo, Cristina Crespo, and Ariel Stern. "Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway." Art. 29. npj Digital Medicine 7 (2024).
- Program
Designing and Executing Corporate Revitalization
Campus Health & Safety Protocols Admissions Criteria and Process We admit candidates to specific sessions on a rolling, space-available basis, and encourage you to apply as early as possible. Although most programs have no formal... View Details
- Program
Making Corporate Boards More Effective
group, and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & Safety Protocols Admissions Criteria and Process We admit candidates to specific sessions on a rolling, space-available basis, and... View Details
- Program
Building a Legacy
immersive experience where every aspect of the learning model has been carefully designed to facilitate your growth. Your learning will take place on your own, in your living group, and in the larger classroom, driven by the renowned HBS case method. Review Our Campus... View Details
- Program
Leading and Building a Culture of Innovation
growth. Your learning will take place on your own, in your living group, and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & Safety Protocols Admissions Criteria and Process We admit candidates... View Details
- Program
Disruptive Innovation
Our Campus Health & Safety Protocols Admissions Criteria and Process We admit candidates to specific sessions on a rolling, space-available basis, and encourage you to apply as early as possible. Although most programs have no formal... View Details
- Program
PLD Module 5
where every aspect of the learning model has been carefully designed to facilitate your growth. Your learning will take place on your own, in your living group, and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & View Details
- 29 Mar 2011
- Working Paper Summaries
Risky Trust: How Multi-entity Teams Develop Trust in a High Risk Endeavor
Keywords: by Faaiza Rashid & Amy C. Edmondson
- September 2021
- Article
Perceptions on Undertaking Regular Asymptomatic Self-testing for COVID-19 Using Lateral Flow Tests: A Qualitative Study of University Students and Staff
By: Marta Wanat, Mary Logan, Jennifer A. Hirst, Charles Vicary, Joseph J. Lee, Rafael Perera, Irene Tracey, Gordon Duff, Peter Tufano, Thomas Fanshawe, Lazaro Mwandigha, Brian D. Nicholson, Sarah Tonkin-Crine and Richard Hobbs
Objectives: Successful implementation of asymptomatic testing programmes using lateral flow tests (LFTs) depends on several factors, including feasibility, acceptability and how people act on test results. We aimed to examine experiences of university students... View Details
Wanat, Marta, Mary Logan, Jennifer A. Hirst, Charles Vicary, Joseph J. Lee, Rafael Perera, Irene Tracey, Gordon Duff, Peter Tufano, Thomas Fanshawe, Lazaro Mwandigha, Brian D. Nicholson, Sarah Tonkin-Crine, and Richard Hobbs. "Perceptions on Undertaking Regular Asymptomatic Self-testing for COVID-19 Using Lateral Flow Tests: A Qualitative Study of University Students and Staff." BMJ Open 11, no. 9 (September 2021).
- 2007
- Article
Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation
By: Arthur A. Daemmrich
In the wake of Vioxx, Avandia, and other recent prominent cases of drugs found to cause side effects after marketing, the safety of pharmaceuticals has come to the forefront of American public policy. Press attention, congressional investigations, and legislative... View Details
Keywords: Brands and Branding; Policy; Risk Management; Government Legislation; Risk and Uncertainty; Goals and Objectives; Customers; Pharmaceutical Industry; Health Industry; United States
Daemmrich, Arthur A. "Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation." Pharmacy in History 49, no. 2 (2007): 61–75.
- 05 Jul 2023
- What Do You Think?
How Are Middle Managers Falling Down Most Often on Employee Inclusion?
underlying employee engagement, retention, and ultimately diversity? Amy Edmondson, in her acclaimed work on these matters, has an interesting comment buried near the back of her book. She says, “Although I’ve been studying psychological View Details
Keywords: by James Heskett
- 06 Nov 2008
- Working Paper Summaries
Extending Producer Responsibility: An Evaluation Framework for Product Take-Back Policies
- November 2017
- Case
The 'Wonder Drug' That Killed Babies
By: Joshua Lev Krieger, Tom Nicholas and Matthew Preble
In the early 1960s, a popular drug taken by patients worldwide for a range of maladies was found to cause severe birth defects and other health problems in babies born to mothers who had taken it during a certain stage of fetal development. As many as 10,000 children... View Details
Keywords: Regulation; Business and Government Relations; Business and Community Relations; Business and Stakeholder Relations; Product Marketing; Corporate Social Responsibility and Impact; Business History; Health; Government Legislation; Corporate Accountability; Ethics; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; Public Administration Industry; United States; United Kingdom; Australia; Germany; Europe
Krieger, Joshua Lev, Tom Nicholas, and Matthew Preble. "The 'Wonder Drug' That Killed Babies." Harvard Business School Case 818-044, November 2017.
- Web
Great American Business Leaders of the 20th Century - Leadership
9 million (largest number since first decade) Baby boomers age Hispanics become fastest-growing minority Population grows from 250 million to 281 million Influence: Medium-High 1900 19 Model T Plastic Safety razor Widespread use of steam... View Details